Evaluation of biomarker canine-prostate specific arginine esterase (CPSE) for the diagnosis of benign prostatic hyperplasia

BACKGROUND: Benign prostatic hyperplasia (BPH) is the most common canine prostatic disorder. Although most or even all intact male dogs may develop BPH by 5–8 years of age, many show no clinical signs. Taking into account the non-specific character of clinical and ultrasonographic findings, a new di...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinheiro, Dora, Machado, João, Viegas, Carlos, Baptista, Cláudia, Bastos, Estela, Magalhães, Joana, Pires, Maria A., Cardoso, Luís, Martins-Bessa, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364560/
https://www.ncbi.nlm.nih.gov/pubmed/28335775
http://dx.doi.org/10.1186/s12917-017-0996-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364560/
https://www.ncbi.nlm.nih.gov/pubmed/28335775
http://dx.doi.org/10.1186/s12917-017-0996-5

Ejemplares similares